Skip to main content
Clinical Trials/NCT02735486
NCT02735486CompletedNot Applicable

Randomized, Controlled Trial of Ginger Extract Consumption for Healthy Males at Risk of Developing Cardiovascular Disease

University of Reading1 site in 1 country22 target enrollmentStarted: February 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
22
Locations
1
Primary Endpoint
Reduction in blood pressure (BP)

Study Overview

Brief Summary

The primary aim of the study was to investigate the acute effect of ginger drink consumption on the risk markers of cardiovascular disease.

Detailed Description

A randomized, single-blind human intervention study involving 22 healthy male volunteers was designed to investigate the acute effects of ginger drink consumption on risk markers of cardiovascular disease (CVD). The primary outcome measure is reduction in blood pressure while the secondary outcome measures are improvement in flow mediated dilatation (FMD) and changes in plasma biochemical profile parameters related to CVD. Participants were given 300 ml of ginger extract or water (placebo) with breakfast, followed by a lunch at 2 hours on two visits separated by 2 weeks. Blood and urine samples were collected at regular intervals as well as blood pressure measurement done during the two visits. Vascular function was measured by flow mediated dilatation (FMD) and pulse wave velocity (PWV) at baseline, 2 and 4 hours after the the consumption of the study drink and placebo. The blood and urine samples were analysed for changes in lipid profile and other markers of CVD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Single (Participant)

Eligibility Criteria

Ages
30 Years to 65 Years (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Apparently healthy males,
  • •Age (30 - 65) years,
  • •Not diabetic or plasma glucose > 7 or on anti-diabetic drugs and not on anti- hypertensive drugs.
  • •Subjects < 10% risk of cardiovascular disease

Exclusion Criteria

  • •Men younger than 30 years and older that 65 years,
  • •Men who are sick or on anti-diabetic and anti-hypertensive drugs.
  • •Men who have history of heart attack or stroke within the last 12 months
  • •Men who are on lipids lowering drugs

Arms & Interventions

Ginger drink

Experimental

Experimental: Ginger drink (300 ml) to be consumed during the study visit

Intervention: Ginger drink (Dietary Supplement)

Placebo: Super pure water

Placebo Comparator

Super Pure water low in nitrate content

Intervention: Placebo: Super pure water (Dietary Supplement)

Outcomes

Primary Outcomes

Reduction in blood pressure (BP)

Time Frame: Six (6) hours

Reduction in blood pressure (BP)

Secondary Outcomes

  • Flow mediated dilatation(Six (6) hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jeremy Paul Edward Spencer

Professor

University of Reading

Study Sites (1)

Loading locations...

Similar Trials